Sara Cales
Medical · Hinton, WVNPI 1265715015
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 142 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $772 and has fallen 73.2% since, to $207 in 2025.
Across 142 payments — averaging $17.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$495
- AstraZeneca$428
- Lilly USA, LLC$332
- Novo Nordisk$222
- Novartis$162
- GSK$147
- plus $648 from 14 others
What the payments were for
- Food & beverage$2,435100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 29 | $495 |
| AstraZeneca | 22 | $428 |
| Lilly USA, LLC | 20 | $332 |
| Novo Nordisk | 13 | $222 |
| Novartis | 9 | $162 |
| GSK | 9 | $147 |
| Amgen | 7 | $107 |
| Boehringer Ingelheim | 6 | $97 |
| Abbott | 4 | $93 |
| Gilead | 5 | $81 |
| Merck | 5 | $70 |
| Exact Sciences | 2 | $41 |
| Pfizer | 2 | $29 |
| Johnson & Johnson | 2 | $29 |
| Amarin Pharma, Inc. | 2 | $26 |
| Scilex Pharmaceuticals Inc. | 1 | $19 |
| Bioventus LLC | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
| Biodelivery Sciences International, Inc. | 1 | $12 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
How this compares
$2,435 in reported general payments places this provider in the 70th percentile of 233 medical providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 105 | $153,217 |
| MounjaroTirzepatide | 96 | $127,684 |
| OzempicSemaglutide | 59 | $101,879 |
| JardianceEmpagliflozin | 69 | $97,489 |
| EliquisApixaban | 49 | $75,975 |
| TradjentaLinagliptin | 38 | $56,810 |
| TrulicityDulaglutide | 40 | $51,993 |
| EntrestoSacubitril/Valsartan | 27 | $47,063 |
| Tresiba Flextouch U-200Insulin Degludec | 34 | $43,723 |
| XareltoRivaroxaban | 22 | $34,588 |
| Repatha SureclickEvolocumab | 48 | $32,710 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 38 | $29,419 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 34 | $26,873 |
| ProliaDenosumab | 12 | $19,856 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $17,729 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $428 | $186,694158 claims |
| Lilly USA, LLCMounjaro, Trulicity | $332 | $179,677136 claims |
| Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat, Stiolto Respimat | $97 | $175,870135 claims |
| Novo NordiskOzempic | $222 | $101,87959 claims |
| PfizerEliquis, Dilantin | $29 | $78,84770 claims |
| NovartisEntresto | $162 | $47,06327 claims |
| Johnson & JohnsonXarelto | $29 | $34,58822 claims |
| GSKTrelegy Ellipta | $147 | $26,87334 claims |
| AmgenProlia | $107 | $19,85612 claims |
| AbbVieLinzess, Synthroid | $495 | $19,47833 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 233 medical providers in West Virginia.
Other medical in Hinton
- Rachelle StewartHinton$4K
- Katherine BoggsSouth Charleston$46K
- Lowell LarewMorgantown$31K
- Katie CarpenterSouth Charleston$26K
- Lauren DillonBeckley$18K
- Angela HagerFarmington$16K
- Brandon CaragCharleston$16K
- Scott EthridgeCharleston$16K
- Kellie HanselSouth Charleston$12K
- Matthew MaynardElkins$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.